Ali O. Güre

Immunology and Microbiology · Life Sciences

37h-index7.8kcitations106works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(36), Cancer-related molecular mechanisms research(18), RNA Interference and Gene Delivery(16), Cancer Cells and Metastasis(15), Monoclonal and Polyclonal Antibodies Research(13)

Publications106 total

Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Retraction Note: TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT
Nature Communications·2023Open Access
A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer
Cancers·2023· 3 citedOpen Access
Supplementary Table 3 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Table 2 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Table 1 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Table 2 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Data from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Table 3 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Table 1 from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Data from Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer
2023Open Access
Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma
Biology·2023· 1 citedOpen Access
Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma Risk
Research Square (Research Square)·2022Open Access
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
Cancers·2021· 10 citedOpen Access
Hypothetical molecular interconnection between type 2 diabetes and dyslexia
BMC Neuroscience·2021· 1 citedOpen Access
Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines
Molecules·2021· 1 citedOpen Access
Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway
Life Sciences·2021· 16 cited
Prognostic value of midkine, syndecan-1, hyaluronansynthase-2, sestrin-1, laminin subunit alpha-4and fibulin-3 for malignant pleural mesothelioma
Archives of Medical Science·2021· 2 citedOpen Access
Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
PLoS ONE·2020· 23 citedOpen Access
Receptor for Advanced Glycation End Products Acts as a Fuel to Colorectal Cancer Development
Frontiers in Oncology·2020· 56 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Lloyd J. Old(28), Matthew J. Scanlan(19), Yao‐Tseng Chen(18), Elisabeth Stockert(13), Alexander Knuth(9), Barbara Williamson(8), Achim A. Jungbluth(8), Elke Jäger(7), Aviram Nissan(7), Gerd Ritter(6), Uğur Şahin(4), Özlem Türeci(4), Solam Tsang(4), Michael Pfreundschuh(4), Andrew J.G. Simpson(4), Nasser K. Altorki(4), Alexander Stojadinovic(4), David Halle(4), Dirk Jäger(4), Murat İşbilen(4)